QL Biopharma raised $72.8M Series C venture round, led by OrbiMed.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
OrbiMedLEAD |
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$145.5M
Top Valuation
-
QL Biopharma raised $72.8M in a Series C round.
The round was announced on 03/01/26.
The round was led by OrbiMed.